Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil.
da Rocha Castelar-Pinheiro G, Vargas-Santos AB, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Resende Guimarães MFB, Bonfiglioli KR, Sauma MFLDC, Pereira IA, Brenol CV, Coutinho ESF, da Mota LMH. da Rocha Castelar-Pinheiro G, et al. Adv Rheumatol. 2018 Jun 28;58(1):9. doi: 10.1186/s42358-018-0017-9. Adv Rheumatol. 2018. PMID: 30657089
Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort.
Gomides APM, de Albuquerque CP, Santos ABV, Amorim RBC, Bértolo MB, Júnior PL, Santos IA, Giorgi RDN, Sacilotto NC, Radominski SC, Borghi FM, Guimarães MFBR, Pinto MRDC, Resende GG, Bonfiglioli KR, Silva HCD, Sauma MFLDC, Sauma ML, de Medeiros JB, Pereira IA, de Castro GRW, Brenol CV, Xavier RM, da Mota LMH, Pinheiro GDRC. Gomides APM, et al. PLoS One. 2019 Mar 1;14(3):e0213219. doi: 10.1371/journal.pone.0213219. eCollection 2019. PLoS One. 2019. PMID: 30822348 Free PMC article.
Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study.
Vicente GNS, Pereira IA, de Castro GRW, da Mota LMH, Carnieletto AP, de Souza DGS, da Gama FO, Santos ABV, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Guimarães MFBR, Bonfiglioli KR, Sauma MFLDC, Brenol CV, da Rocha Castelar Pinheiro G. Vicente GNS, et al. Among authors: giorgi rdn. Adv Rheumatol. 2021 Jun 25;61(1):38. doi: 10.1186/s42358-021-00186-4. Adv Rheumatol. 2021. PMID: 34172097
[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].
Mota LM, Cruz BA, Brenol CV, Pollak DF, Pinheiro Gda R, Laurindo IM, Pereira IA, Carvalho JF, Bertolo MB, Pinheiro Mde M, Freitas MV, Silva NA, Louzada-Júnior P, Sampaio-Barros PD, Giorgi RD, Lima RA, Andrade LE. Mota LM, et al. Among authors: giorgi rd. Rev Bras Reumatol. 2015 May-Jun;55(3):281-309. doi: 10.1016/j.rbr.2014.06.006. Epub 2014 Oct 13. Rev Bras Reumatol. 2015. PMID: 26054442 Free article. Review. Portuguese.
Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.
da Mota LM, Cruz BA, de Albuquerque CP, Gonçalves DP, Laurindo IM, Pereira IA, de Carvalho JF, Pinheiro Gda R, Bertolo MB, Pinto MR, Louzada-Junior P, Xavier RM, Giorgi RD, Lima RA. da Mota LM, et al. Among authors: giorgi rd. Rev Bras Reumatol. 2015 Nov-Dec;55(6):512-21. doi: 10.1016/j.rbr.2015.08.004. Epub 2015 Sep 26. Rev Bras Reumatol. 2015. PMID: 26456224 Free article. Review. English, Portuguese.
2017 recommendations of the Brazilian Society of Rheumatology for the pharmacological treatment of rheumatoid arthritis.
Mota LMHD, Kakehasi AM, Gomides APM, Duarte ALBP, Cruz BA, Brenol CV, de Albuquerque CP, Castelar Pinheiro GDR, Laurindo IMM, Pereira IA, Bertolo MB, Ubirajara Silva de Souza MPG, de Freitas MVC, Louzada-Júnior P, Xavier RM, Giorgi RDN. Mota LMHD, et al. Adv Rheumatol. 2018 May 24;58(1):2. doi: 10.1186/s42358-018-0005-0. Adv Rheumatol. 2018. PMID: 30657071
31 results